Author

Alexander Grenander Raufi

Brown UniversityORCID 0000-0001-5645-2629Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Alina Cornelia IugaiD· 1 shared Andrew CheniD· 1 shared Anthony M. ReginatoiD· 1 shared Bedia AkosmaniD· 1 shared Carmine F. PalermoiD· 1 shared Clark C. CheniD· 1 shared Emily Linda AlouaniiD· 1 shared Eric T. WongiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alina Cornelia IugaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Therapy OncologyPeer-reviewedApr 8, 2026

Enabling CAR-T Cell Immunotherapy in Glioblastoma by Modifying Tumor Microenvironment via Oncolytic Adenovirus Encoding Bispecific T Cell Engager

Moon Jung Choi, Eui Young So, Bedia Akosman…·Olin D. Liang

This paper demonstrates that combining oncolytic adenovirus encoding bispecific T cell engager (OV-BiTE) with CAR-T cells enhances T cell recruitment and tumor eradication in glioblastoma xenograft models.

DOI 10.1016/j.omton.2026.201201

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 24, 2023

Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma

Alexander Grenander Raufi, Ilenia Pellicciotta, Carmine F. Palermo…·Gulam Abbas Manji

This study shows that combining gemcitabine with CXCR4 inhibitors and anti-PD1 therapy improves immune response and survival in pancreatic cancer models.

7 citations

humanmouse

𝕏 PostBluesky